Lexaria Bioscience Corp (LEXX) — Strategic Asset Allocation Index
Lexaria Bioscience Corp (LEXX) has a Strategic Asset Allocation Index of 11.3% as of May 2023. Strategic assets (PP&E of $455.02K plus long-term investments of $-) total $455.02K, measured against net assets of $4.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check LEXX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Lexaria Bioscience Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how Lexaria Bioscience Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of May 2023, the index stands at 11.3%, representing strategic assets of $455.02K against net assets of $4.04 Million USD. See LEXX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Lexaria Bioscience Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lexaria Bioscience Corp from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Lexaria Bioscience Corp.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.8% | $367.95K | $367.95K | $- | $7.63 Million | ▲ +1.3 pp |
| 2021 | 3.5% | $459.25K | $459.25K | $- | $13.06 Million | ▼ -21.1 pp |
| 2020 | 24.6% | $610.28K | $610.28K | $- | $2.48 Million | ▲ +0.8 pp |
| 2019 | 23.7% | $591.26K | $591.26K | $- | $2.49 Million | ▲ +23.7 pp |
| 2018 | 0.1% | $1.24K | $1.24K | $- | $2.39 Million | ▼ 0.0 pp |
| 2017 | 0.1% | $1.86K | $1.86K | $- | $2.77 Million | — |